UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Progestogen-only contraception in women at high risk of venous thromboembolism

Contraception (Stoneham), 2004-12, Vol.70 (6), p.437-441

2004

Volltextzugriff (PDF)

Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.e347-e348

2016

Volltextzugriff (PDF)

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

Stroke (1970), 1996-10, Vol.27 (10), p.1724-1730

1996

Volltextzugriff (PDF)

A vitamin K epoxide reductase complex subunit‐1 (VKORC1) mutation in a patient with vitamin K antagonist resistance

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1533-1535

2005

Volltextzugriff (PDF)

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

Thrombosis and haemostasis, 2008-03, Vol.99 (3), p.616

2008

Volltextzugriff (PDF)

Acquired hemophilia due to factor VIII inhibitors in 34 patients

The American journal of medicine, 1998-11, Vol.105 (5), p.400-408

1998

Volltextzugriff (PDF)

A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism

American journal of respiratory and critical care medicine, 2000-10, Vol.162 (4), p.1413-1418

2000

Volltextzugriff (PDF)

Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bβ Y236C and Bβ IVS7‐1G→C mutations

Journal of thrombosis and haemostasis, 2006-05, Vol.4 (5), p.1134-1136

2006

Volltextzugriff (PDF)

A Single Genetic Origin for the Common Prothrombotic G20210A Polymorphism in the Prothrombin Gene

Blood, 1998-08, Vol.92 (4), p.1119-1124

1998

Volltextzugriff (PDF)

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

British journal of haematology, 2003-10, Vol.123 (2), p.327-334

2003

Volltextzugriff (PDF)

Frequency of the 20210 G→A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis

Stroke (1970), 1998-07, Vol.29 (7), p.1398-1400

1998

Volltextzugriff (PDF)

Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women

Thrombosis and haemostasis, 1990-04, Vol.63 (2), p.319

1990

Volltextzugriff (PDF)

European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point‐of‐care prothrombin time monitor systems

British journal of haematology, 2002-03, Vol.116 (4), p.844-850

2002

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia : laboratory diagnosis and management

Annals of medicine (Helsinki), 2000-12, Vol.32, p.60-67

2000

Volltextzugriff (PDF)

Inherited Thrombophilia and Gestational Venous Thromboembolism

Seminars in thrombosis and hemostasis, 2003-04, Vol.29 (2), p.131-142

2003

Volltextzugriff (PDF)

Modified APC resistance assay for patients on oral anticoagulants

The Lancet (British edition), 1994-12, Vol.344 (8938), p.1709-1709

1994

Volltextzugriff (PDF)

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation

Thrombosis research, 2002-07, Vol.107 (1), p.7-11

2002

Volltextzugriff (PDF)

Diagnostic de résistance à la protéine C activée par test chronométrique et par biologie moléculaire

La revue de medecine interne, 1995, Vol.16 (6), p.462-463

1995

Volltextzugriff (PDF)

Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode

International angiology, 2003-12, Vol.22 (4), p.364

2003

Volltextzugriff (PDF)

Leu 697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease

Blood, 1994-03, Vol.83 (6), p.1542-1550

1994

Volltextzugriff (PDF)

Leiden factor V mutation in four patients with small bowel infarctions

Gastroenterology (New York, N.Y. 1943), 1997-07, Vol.113 (1), p.322-325

1997

Volltextzugriff (PDF)

Biochemistry and clinical pharmacology of new anticoagulant agents

Pathophysiology of haemostasis and thrombosis, 2002-09, Vol.32 (5-6), p.218-224

2002

Volltextzugriff (PDF)

The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant

Thrombosis and haemostasis, 1996-03, Vol.75 (3), p.521

1996

Volltextzugriff (PDF)

Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin

Thrombosis and haemostasis, 1998-07, Vol.80 (1), p.104

1998

Volltextzugriff (PDF)

Central Retinal Vein Thrombosis Associated With Resistance to Activated Protein C

American journal of ophthalmology, 1995-09, Vol.120 (3), p.388-389

1995

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(85)
Science & Technology
(85)
Humans
(82)
Female
(48)
Hematology
(47)
Adult
(44)
Biological And Medical Sciences
(40)
Male
(39)
Medical Sciences
(37)
Middle Aged
(37)
Cardiovascular System & Cardiology
(27)
Peripheral Vascular Disease
(26)
Aged
(22)
Adolescent
(17)
General & Internal Medicine
(15)
Medicine, General & Internal
(14)
Anticoagulants - Therapeutic Use
(13)
Hematologic And Hematopoietic Diseases
(13)
Pharmacology. Drug Treatments
(13)
Platelet Diseases And Coagulopathies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(14)
Thrombosis And Haemostasis
(13)
Haemostasis
(8)
Pathophysiology Of Haemostasis And Thrombosis
(8)
La Revue De Medecine Interne
(5)
The Lancet
(5)
Thrombosis Research
(5)
British Journal Of Haematology
(3)
La Presse Médicale
(3)
Stroke
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Progestogen-only contraception in women at high risk of venous thromboembolism

Is there a role for antiangiogenic therapy, bevacizumab, in the treatment of recurrent digestive bleeding due to angiodysplasia in Glanzmann's thrombasthenia?

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

A vitamin K epoxide reductase complex subunit‐1 (VKORC1) mutation in a patient with vitamin K antagonist resistance

Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations

Acquired hemophilia due to factor VIII inhibitors in 34 patients

A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism

Fibrinogen Paris IX: a case of symptomatic hypofibrinogenemia with Bβ Y236C and Bβ IVS7‐1G→C mutations

A Single Genetic Origin for the Common Prothrombotic G20210A Polymorphism in the Prothrombin Gene

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

Frequency of the 20210 G→A mutation in the 3'-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis

Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women

European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point‐of‐care prothrombin time monitor systems

Heparin-induced thrombocytopenia : laboratory diagnosis and management

Inherited Thrombophilia and Gestational Venous Thromboembolism

Modified APC resistance assay for patients on oral anticoagulants

Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation

Diagnostic de résistance à la protéine C activée par test chronométrique et par biologie moléculaire

Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode

Leu 697 → Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease

Leiden factor V mutation in four patients with small bowel infarctions

Biochemistry and clinical pharmacology of new anticoagulant agents

The modified APC resistance test in the presence of factor V deficient plasma can be used in patients without oral anticoagulant

Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin

Central Retinal Vein Thrombosis Associated With Resistance to Activated Protein C

Suchergebnisse filtern